$QXO
QXO, Inc. Stock $qxo

$qxo Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000118518523000457 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$13.26M	$13.13M	$11.02M
YoY Change	24.62%	19.08%	1.32%
Cost Of Revenue	$8.072M	$7.770M	$6.365M
YoY Change	23.98%	22.08%	3.83%
Gross Profit	$5.185M	$5.358M	$4.659M
YoY Change	25.63%	15.0%	-1.92%
Gross Profit Margin	39.11%	40.81%	42.26%
Selling, General & Admin	$4.525M	$4.739M	$4.417M
YoY Change	15.32%	7.29%	9.06%
% of Gross Profit	87.27%	88.45%	94.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$85.53K	$92.54K	$288.9K
YoY Change	-11.44%	-67.97%	44.45%
% of Gross Profit	1.65%	1.73%	6.2%
Operating Expenses	$4.729M	$4.988M	$4.679M
YoY Change	12.42%	6.61%	9.83%
Operating Profit	$456.3K	$369.5K	-$19.72K
YoY Change	-675.76%	-1973.92%	-104.02%
Interest Expense	$17.42K	$17.26K	-$18.85K
YoY Change	-26.8%	-191.54%	88.5%
% of Operating Profit	3.82%	4.67%
Other Income/Expense, Net	-$17.42K	-$17.26K	-$18.85K
YoY Change	-26.8%	-8.47%
Pretax Income	$438.8K	$352.3K	-$38.57K
YoY Change	-525.87%	-1013.36%	-108.04%
Income Tax	$95.48K	$74.79K	$2.090K
% Of Pretax Income	21.76%	21.23%
Net Earnings	$343.4K	$277.5K	-$40.66K
YoY Change	-491.22%	-782.47%	-111.62%
Net Earnings / Revenue	2.59%	2.11%	-0.37%
Basic Earnings Per Share	$0.07
Diluted Earnings Per Share	$0.07	$0.05	-$7.916K
COMMON SHARES
Basic Shares Outstanding	5.256M shares	5.256M shares	5.136M shares
Diluted Shares Outstanding	5.256M shares	5.256M shares	5.136M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.130M	$6.876M	$6.486M
YoY Change	21.39%	6.0%	-30.7%
Cash & Equivalents	$7.130M	$6.876M	$6.486M
Short-Term Investments
Other Short-Term Assets	$3.568M	$3.534M	$1.488M
YoY Change	140.23%	137.49%	59.99%
Inventory
Prepaid Expenses
Receivables	$2.228M	$2.231M	$2.384M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.43M	$13.58M	$10.36M
YoY Change	34.94%	31.09%	-18.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$557.1K	$623.8K	$1.173M
YoY Change	-37.75%	-46.84%	-34.09%
Goodwill	$1.140M	$1.140M
YoY Change	12.65%
Intangibles	$3.941M	$4.103M
YoY Change	-17.01%
Long-Term Investments
YoY Change
Other Assets	$187.6K	$187.6K	$1.180M
YoY Change	-0.69%	-84.1%	6.28%
Total Long-Term Assets	$7.177M	$7.525M	$8.300M
YoY Change	-14.16%	-9.34%	20.12%
TOTAL ASSETS
Total Short-Term Assets	$13.43M	$13.58M	$10.36M
Total Long-Term Assets	$7.177M	$7.525M	$8.300M
Total Assets	$20.60M	$21.10M	$18.66M
YoY Change	12.52%	13.1%	-4.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.821M	$2.847M	$2.074M
YoY Change	45.19%	37.25%	43.03%
Accrued Expenses	$2.175M	$2.213M	$2.262M
YoY Change	51.13%	-2.17%	22.92%
Deferred Revenue
YoY Change
Short-Term Debt	$103.3K	$103.3K	$103.3K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$477.1K	$510.5K	$672.1K
YoY Change	-10.0%	-24.04%	68.02%
Total Short-Term Liabilities	$9.469M	$10.22M	$7.723M
YoY Change	31.51%	32.29%	17.36%
LONG-TERM LIABILITIES
Long-Term Debt	$451.7K	$551.3K	$1.318M
YoY Change	-53.95%	-58.15%	135.27%
Other Long-Term Liabilities	$162.3K	$111.5K	$256.2K
YoY Change	-13.94%	-56.47%	-67.16%
Total Long-Term Liabilities	$451.7K	$551.3K	$1.574M
YoY Change	-53.95%	-64.96%	17.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.469M	$10.22M	$7.723M
Total Long-Term Liabilities	$451.7K	$551.3K	$1.574M
Total Liabilities	$10.39M	$11.23M	$9.296M
YoY Change	15.54%	20.82%	17.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$255.7K	-$599.1K
YoY Change	-64.62%
Common Stock	$53.00	$53.00
YoY Change	1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.21M	$9.871M	$9.362M
YoY Change
Total Liabilities & Shareholders Equity	$20.60M	$21.10M	$18.66M
YoY Change	12.52%	13.1%	-4.85%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$343.4K	$277.5K	-$40.66K
YoY Change	-491.22%	-782.47%	-111.62%
Depreciation, Depletion And Amortization	$85.53K	$92.54K	$288.9K
YoY Change	-11.44%	-67.97%	44.45%
Cash From Operating Activities	$459.3K	-$783.1K	-$8.250K
YoY Change	-196.27%	9391.66%	-98.35%
INVESTING ACTIVITIES
Capital Expenditures	$18.88K	$4.979K	-$30.55K
YoY Change	-112.59%	-116.3%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$150.0K
YoY Change		-100.0%
Cash From Investing Activities	-$18.88K	-$4.979K	-$180.6K
YoY Change		-97.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$289.3K	$81.90K
YoY Change		253.22%
Cash From Financing Activities	-186.4K	-$344.8K	-138.9K
YoY Change	37.36%	148.26%	-104.26%
NET CHANGE
Cash From Operating Activities	459.3K	-$783.1K	-8.250K
Cash From Investing Activities	-18.88K	-$4.979K	-180.6K
Cash From Financing Activities	-186.4K	-$344.8K	-138.9K
Net Change In Cash	254.0K	-$1.133M	-327.7K
YoY Change	-141.45%	245.71%	-111.87%
FREE CASH FLOW
Cash From Operating Activities	$459.3K	-$783.1K	-$8.250K
Capital Expenditures	$18.88K	$4.979K	-$30.55K
Free Cash Flow	$440.4K	-$788.0K	$22.30K
YoY Change	-234.65%	-3633.82%	-104.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	445755	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38063
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SILVERSUN TECHNOLOGIES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1633636
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Eagle Rock Ave
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	East Hanover
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07936
CY2023Q1	dei	City Area Code CityAreaCode	973
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	396-1720
CY2023Q1	dei	Security12g Title Security12gTitle	Common Stock, par value $0.00001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	SSNT
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5256177	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6875779	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8008633	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	514775	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	490311	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2231405	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2232960	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	937418	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	367165	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	1792190	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1516895	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1741412	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1573615	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	13578204	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13699268	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	623752	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	711314	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	328562	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4103392	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4265353	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1139952	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1139952	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5256177	shares
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1024486	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1106065	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	187553	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	187553	usd
CY2023Q1	us-gaap	Assets Assets	21103094	usd
CY2022Q4	us-gaap	Assets Assets	21438067	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2846568	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3272555	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2212680	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2432703	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	23942	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	23757	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	510530	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	680146	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	103333	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	103333	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	208511	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	214990	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	334237	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268345	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3976574	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3757090	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10216375	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10752919	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	551342	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	671014	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	352407	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	401453	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	111518	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	60217	usd
CY2023Q1	us-gaap	Liabilities Liabilities	11231642	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11885603	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5256177	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5256177	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5256177	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	53	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	53	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10470498	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10429001	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-599099	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-876590	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9871452	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9552464	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21103094	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21438067	usd
CY2023Q1	us-gaap	Revenues Revenues	13127738	usd
CY2022Q1	us-gaap	Revenues Revenues	11023844	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	7770178	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6318977	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	5357560	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	4704867	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2178703	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1775811	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2560028	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2640977	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	41497	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45945	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	207795	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	261850	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4988023	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4724583	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	369537	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19716	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	17255	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	18852	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17255	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18852	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	352282	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38568	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74791	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2088	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	277491	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40656	usd
CY2023Q1	ssnt	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0.05
CY2022Q1	ssnt	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5256177	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5136177	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5256177	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5136177	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9552464	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	41497	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	277491	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9871452	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	81901	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9356823	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	45945	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40656	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9362112	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	277491	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-40656	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-81579	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2088	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92541	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98425	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	161961	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	190457	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	99118	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	360768	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24464	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41497	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45945	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22909	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-164565	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	570253	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	337150	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	275295	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	167797	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	302141	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-425987	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35918	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-220023	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	147344	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	185	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-5592	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	219484	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7449	usd
CY2023Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	99118	usd
CY2022Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	360768	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-783062	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8246	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4979	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30548	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	150000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4979	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-180548	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	289288	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	55525	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	56989	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-344813	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10178	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-138890	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1132854	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-327684	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8008633	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6814117	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6875779	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6486433	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	40491	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	24534	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	6679	usd
CY2022Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	73672	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Use of Estimates </span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	514775	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	490311	usd
CY2023Q1	us-gaap	Revenues Revenues	13127738	usd
CY2022Q1	us-gaap	Revenues Revenues	11023844	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	644367	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Concentrations</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash with various institutions, which exceed federally insured limits throughout the year. At March 31, 2023 and December 31, 2022, the Company had cash on deposit of $5,690,968 and $7,050,862, respectively, in excess of the federally insured limits of $250,000.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of March 31, 2023, no one customer represented more than 10% of the total accounts receivable and unbilled services. As of December 31, 2022, no one customer represented more than 10% of the total accounts receivable and unbilled services.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the three months ended March 31, 2023 and 2022, the Company’s top ten customers accounted for 10% ($1,329,501) and 11% ($1,218,890), respectively, of total revenues. The Company does not rely on any one specific customer for any significant portion of its revenue.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the three months ended March 31, 2023 and 2022 purchases from one supplier through a “channel partner” agreement were approximately 14% and 11% of cost of revenues, respectively. The channel partner agreements are for a one-year term and automatically renew for an additional one-year term on the anniversary of the agreement’s effective date.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of March 31, 2023, one supplier represented approximately 25% of total accounts payable. For the year ended December 31, 2022, one supplier represented approximately 28% of total accounts payable.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and cash. As of March 31, 2023, the Company believes it has no significant risk related to its concentration of credit risk related to accounts receivable.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5690968	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	7050862	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	25000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	170178	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	536	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	277491	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40656	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5256177	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5136177	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	277491	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40656	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5256177	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5136177	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5256177	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5136177	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.01
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	158420	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	165620	shares
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	490311	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	330311	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3992255	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3987276	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3368503	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3275962	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	623752	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	711314	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92541	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98425	usd
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	1335000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	500000	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	835000	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325	pure
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8133365	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8133365	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4029973	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3868012	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4103392	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4265353	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	161961	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	190457	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	485883	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	647844	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	643013	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	633165	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	619516	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1072617	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4103392	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1165205	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1454493	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	613863	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	783479	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	494190	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	360091	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	258736	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	52188	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1165205	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0727	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M8D
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	186413	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	177214	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	115608	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	115608	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	48170	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7200	shares
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	82095	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	560918	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	208511	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	352407	usd
CY2023Q1	ssnt	Number Of Locations Of Office Space Leases NumberOfLocationsOfOfficeSpaceLeases	4	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0477	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M23D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M8D
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	272712	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	157958	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	31800	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	462470	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	16715	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	445755	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	334237	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	111518	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	82666	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	119329	usd
CY2019Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	5000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	165620	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.256
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.53
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	158420	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.245
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	158420	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.245
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41497	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45945	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	41497	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5000000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1024000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1106000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74791	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2088	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	103333	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	103333	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001236275

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001185185-23-000457-index-headers.html	Edgar Link	pending
0001185185-23-000457-index.html	Edgar Link	pending
0001185185-23-000457.txt	Edgar Link	pending
0001185185-23-000457-xbrl.zip	Edgar Link	pending
ex_513988.htm	Edgar Link	pending
ex_513989.htm	Edgar Link	pending
ex_513990.htm	Edgar Link	pending
ex_513991.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
silversun20230331_10q.htm	Edgar Link	pending
ssnt-20230331.xsd	Edgar Link	pending
ssnt-20230331_def.xml	Edgar Link	unprocessable
ssnt-20230331_cal.xml	Edgar Link	unprocessable
ssnt-20230331_pre.xml	Edgar Link	unprocessable
ssnt-20230331_lab.xml	Edgar Link	unprocessable
silversun20230331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QXO
QXO, Inc. Stock $qxo

2023 Q2 Form 10-Q Financial Statement

#000118518523000457 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QXO QXO, Inc. Stock $qxo

2023 Q2 Form 10-Q Financial Statement

#000118518523000457 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QXO
QXO, Inc. Stock $qxo